Skip to main content
. 2018 Nov 15;3(11):15546–15553. doi: 10.1021/acsomega.8b01668

Table 2. Method Validation of HILIC–MS/MS for 17 Glucosinolates with Available Standardsa.

  calibration curve
      accuracy (%)
recovery (%)
glucosinolates formulation R2 concentration (ng/mL) LOD (μg/g dry weight) LOQ intrabatch interbatch low high
sinigrin y = 0.037x – 0.106 0.9997 1–500 0.007 0.023 4.35 5.96 79.44 103.06
glucoiberin y = 0.006x + 0.012 0.9994 1–500 0.003 0.010 4.82 6.32 112.10 84.36
glucocheirolin y = 0.038x – 0.036 0.9998 1–500 0.004 0.013 4.17 3.34 95.74 106.37
glucoerucin y = 0.073x – 0.725 0.9991 1–1000 0.009 0.030 7.21 6.76 84.04 110.19
glucoraphenin y = 0.47x – 1.149 0.9985 1–500 0.001 0.003 2.00 8.85 90.45 84.25
glucoraphanin y = 0.018x – 0.020 0.9998 1–500 0.013 0.043 4.06 7.67 85.26 98.40
gluconapin y = 0.054x – 0.012 0.9999 1–250 0.003 0.010 8.61 5.96 78.36 87.43
epiprogoitrin y = 0.033x – 0.068 0.9994 1–250 0.007 0.023 6.10 5.70 117.01 96.59
progoitrin y = 0.015x – 0.061 0.9997 1–1000 0.028 0.093 4.23 5.35 84.69 95.64
glucoalyssin y = 0.017x + 0.029 0.9991 1–500 0.013 0.043 6.74 9.04 95.26 114.17
glucobrassicanapin y = 0.079x – 0.936 0.9987 1–1000 0.008 0.027 9.24 9.95 81.67 91.45
glucobrassicin y = 0.042x – 0.133 0.9995 1–500 0.019 0.063 5.51 8.75 92.30 120.31
4-hydroxyglucobrassicin y = 0.004x – 0.016 0.9996 1–1000 0.021 0.070 2.43 9.02 76.46 107.01
glucotropaeolin y = 0.082x – 0.265 0.9998 1–500 0.004 0.013 5.58 7.29 120.14 106.33
gluconasturtiin y = 0.052x – 0.129 0.9990 1–500 0.006 0.020 4.29 7.16 105.76 102.56
glucobarbarin y = 0.002x + 0.003 0.9979 5–500 0.023 0.077 6.54 3.33 114.79 99.05
glucosinalbin y = 0.003x + 0.008 0.9991 5–500 0.007 0.023 2.02 8.99 95.01 101.22
a

LOD, limit of detection; LOQ, limit of quantification.